Endo International PLC (NASDAQ:ENDP) Sees Significant Increase in Short Interest

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 35,835,900 shares, a growth of 24.6% from the July 31st total of 28,757,700 shares. Currently, 17.7% of the company’s shares are short sold. Based on an average daily volume of 5,850,000 shares, the days-to-cover ratio is presently 6.1 days.

Several equities analysts have recently issued reports on ENDP shares. Zacks Investment Research lowered Endo International from a “buy” rating to a “hold” rating in a research report on Wednesday, May 15th. ValuEngine lowered Endo International from a “sell” rating to a “strong sell” rating in a research report on Tuesday, May 28th. BidaskClub lowered Endo International from a “sell” rating to a “strong sell” rating in a research report on Thursday, July 18th. Cantor Fitzgerald decreased their target price on Endo International from $18.00 to $4.75 and set a “neutral” rating for the company in a research report on Wednesday, June 12th. Finally, Barclays started coverage on Endo International in a research report on Tuesday, June 11th. They set an “equal weight” rating and a $6.00 target price for the company. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $7.89.

Shares of ENDP traded down $0.09 on Thursday, hitting $3.96. The company’s stock had a trading volume of 8,553,003 shares, compared to its average volume of 4,906,761. The firm’s fifty day moving average price is $2.77 and its 200-day moving average price is $5.64. Endo International has a fifty-two week low of $1.97 and a fifty-two week high of $18.50. The firm has a market capitalization of $907.83 million, a price-to-earnings ratio of 1.37 and a beta of 1.23.



Endo International (NASDAQ:ENDP) (TSE:ENL) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.05. Endo International had a negative return on equity of 129.30% and a negative net margin of 19.98%. The business had revenue of $699.71 million during the quarter, compared to analyst estimates of $694.60 million. During the same period in the previous year, the firm earned $0.76 EPS. Endo International’s quarterly revenue was down 2.1% compared to the same quarter last year. Sell-side analysts expect that Endo International will post 2.17 EPS for the current year.

In other Endo International news, Director Roger H. Kimmel sold 34,951 shares of the business’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $3.93, for a total transaction of $137,357.43. Following the completion of the sale, the director now directly owns 148,309 shares of the company’s stock, valued at approximately $582,854.37. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.50% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Meeder Asset Management Inc. grew its position in shares of Endo International by 47.1% in the 2nd quarter. Meeder Asset Management Inc. now owns 37,887 shares of the company’s stock valued at $156,000 after purchasing an additional 12,127 shares during the period. Factorial Partners LLC acquired a new position in Endo International during the 1st quarter worth approximately $193,000. Nordea Investment Management AB boosted its position in Endo International by 37.5% during the 1st quarter. Nordea Investment Management AB now owns 177,700 shares of the company’s stock worth $1,427,000 after acquiring an additional 48,500 shares during the last quarter. Arizona State Retirement System boosted its position in Endo International by 1.4% during the 2nd quarter. Arizona State Retirement System now owns 312,262 shares of the company’s stock worth $1,287,000 after acquiring an additional 4,167 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its position in Endo International by 61.2% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 3,063,703 shares of the company’s stock worth $12,622,000 after acquiring an additional 1,163,289 shares during the last quarter. Institutional investors and hedge funds own 95.80% of the company’s stock.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Recommended Story: Forex

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.